Monoclonal antibodies reactive with the angiostatin receptor to replace angiostatin as an anti-tumor agent

Principal Investigator: Carol J. Wikstrand, PhD

Initiative: Unrestricted Grant

Institute: Duke University Medical Center

Location: Durham, NC